[1]
Vincent JM, Morrison ID, Armstrong P, Reznek RH. The size of normal adrenal glands on computed tomography. Clinical radiology. 1994 Jul:49(7):453-5
[PubMed PMID: 8088036]
[2]
Lila AR, Sarathi V, Jagtap VS, Bandgar T, Menon P, Shah NS. Cushing's syndrome: Stepwise approach to diagnosis. Indian journal of endocrinology and metabolism. 2011 Oct:15 Suppl 4(Suppl4):S317-21. doi: 10.4103/2230-8210.86974. Epub
[PubMed PMID: 22145134]
[3]
Ejaz S, Vassilopoulou-Sellin R, Busaidy NL, Hu MI, Waguespack SG, Jimenez C, Ying AK, Cabanillas M, Abbara M, Habra MA. Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center Experience. Cancer. 2011 Oct 1:117(19):4381-9. doi: 10.1002/cncr.26029. Epub 2011 Mar 15
[PubMed PMID: 21412758]
[4]
Chaudhary V, Bano S. Imaging of the pituitary: Recent advances. Indian journal of endocrinology and metabolism. 2011 Sep:15 Suppl 3(Suppl3):S216-23. doi: 10.4103/2230-8210.84871. Epub
[PubMed PMID: 22029027]
Level 3 (low-level) evidence
[5]
Manipadam MT, Abraham R, Sen S, Simon A. Primary pigmented nodular adrenocortical disease. Journal of Indian Association of Pediatric Surgeons. 2011 Oct:16(4):160-2. doi: 10.4103/0971-9261.86881. Epub
[PubMed PMID: 22121318]
[6]
New MI, Wilson RC. Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess. Proceedings of the National Academy of Sciences of the United States of America. 1999 Oct 26:96(22):12790-7
[PubMed PMID: 10536001]
[7]
De Venanzi A, Alencar GA, Bourdeau I, Fragoso MC, Lacroix A. Primary bilateral macronodular adrenal hyperplasia. Current opinion in endocrinology, diabetes, and obesity. 2014 Jun:21(3):177-84. doi: 10.1097/MED.0000000000000061. Epub
[PubMed PMID: 24739311]
Level 3 (low-level) evidence
[8]
Young WF Jr, Carney JA, Musa BU, Wulffraat NM, Lens JW, Drexhage HA. Familial Cushing's syndrome due to primary pigmented nodular adrenocortical disease. Reinvestigation 50 years later. The New England journal of medicine. 1989 Dec 14:321(24):1659-64
[PubMed PMID: 2586567]
[9]
Zhou J, Zhang M, Bai X, Cui S, Pang C, Lu L, Pang H, Guo X, Wang Y, Xing B. Demographic Characteristics, Etiology, and Comorbidities of Patients with Cushing's Syndrome: A 10-Year Retrospective Study at a Large General Hospital in China. International journal of endocrinology. 2019:2019():7159696. doi: 10.1155/2019/7159696. Epub 2019 Feb 19
[PubMed PMID: 30915114]
Level 2 (mid-level) evidence
[10]
Bertherat J, Horvath A, Groussin L, Grabar S, Boikos S, Cazabat L, Libe R, René-Corail F, Stergiopoulos S, Bourdeau I, Bei T, Clauser E, Calender A, Kirschner LS, Bertagna X, Carney JA, Stratakis CA. Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. The Journal of clinical endocrinology and metabolism. 2009 Jun:94(6):2085-91. doi: 10.1210/jc.2008-2333. Epub 2009 Mar 17
[PubMed PMID: 19293268]
[11]
Bourdeau I, D'Amour P, Hamet P, Boutin JM, Lacroix A. Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome. The Journal of clinical endocrinology and metabolism. 2001 Nov:86(11):5534-40
[PubMed PMID: 11701732]
[12]
Vassiliadi DA, Ntali G, Stratigou T, Adali M, Tsagarakis S. Aberrant cortisol responses to physiological stimuli in patients presenting with bilateral adrenal incidentalomas. Endocrine. 2011 Dec:40(3):437-44. doi: 10.1007/s12020-011-9490-1. Epub 2011 May 20
[PubMed PMID: 21598069]
[13]
Louiset E, Duparc C, Young J, Renouf S, Tetsi Nomigni M, Boutelet I, Libé R, Bram Z, Groussin L, Caron P, Tabarin A, Grunenberger F, Christin-Maitre S, Bertagna X, Kuhn JM, Anouar Y, Bertherat J, Lefebvre H. Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia. The New England journal of medicine. 2013 Nov 28:369(22):2115-25. doi: 10.1056/NEJMoa1215245. Epub
[PubMed PMID: 24283225]
[14]
Assié G, Libé R, Espiard S, Rizk-Rabin M, Guimier A, Luscap W, Barreau O, Lefèvre L, Sibony M, Guignat L, Rodriguez S, Perlemoine K, René-Corail F, Letourneur F, Trabulsi B, Poussier A, Chabbert-Buffet N, Borson-Chazot F, Groussin L, Bertagna X, Stratakis CA, Ragazzon B, Bertherat J. ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome. The New England journal of medicine. 2013 Nov 28:369(22):2105-14. doi: 10.1056/NEJMoa1304603. Epub
[PubMed PMID: 24283224]
[15]
Carney JA, Young WF, Stratakis CA. Primary bimorphic adrenocortical disease: cause of hypercortisolism in McCune-Albright syndrome. The American journal of surgical pathology. 2011 Sep:35(9):1311-26. doi: 10.1097/PAS.0b013e31821ec4ce. Epub
[PubMed PMID: 21836496]
[16]
Sasano H, Suzuki T, Nagura H. ACTH-independent macronodular adrenocortical hyperplasia: immunohistochemical and in situ hybridization studies of steroidogenic enzymes. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 1994 Feb:7(2):215-9
[PubMed PMID: 8008746]
[17]
Iseli BE, Hedinger CE. Histopathology and ultrastructure of primary adrenocortical nodular dysplasia with Cushing's syndrome. Histopathology. 1985 Nov:9(11):1171-94
[PubMed PMID: 4085982]
[18]
Shenoy BV, Carpenter PC, Carney JA. Bilateral primary pigmented nodular adrenocortical disease. Rare cause of the Cushing syndrome. The American journal of surgical pathology. 1984 May:8(5):335-44
[PubMed PMID: 6329005]
[19]
Sasano H, Miyazaki S, Sawai T, Sasano N, Nagura H, Funahashi H, Aiba M, Demura H. Primary pigmented nodular adrenocortical disease (PPNAD): immunohistochemical and in situ hybridization analysis of steroidogenic enzymes in eight cases. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 1992 Jan:5(1):23-9
[PubMed PMID: 1542635]
[20]
Travis WD, Tsokos M, Doppman JL, Nieman L, Chrousos GP, Cutler GB Jr, Loriaux DL, Norton JA. Primary pigmented nodular adrenocortical disease. A light and electron microscopic study of eight cases. The American journal of surgical pathology. 1989 Nov:13(11):921-30
[PubMed PMID: 2679153]
[21]
Schteingart DE. The clinical spectrum of adrenocortical hyperplasia. Current opinion in endocrinology, diabetes, and obesity. 2012 Jun:19(3):176-82. doi: 10.1097/MED.0b013e3283537ee9. Epub
[PubMed PMID: 22499224]
[22]
Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism. 2008 May:93(5):1526-40. doi: 10.1210/jc.2008-0125. Epub 2008 Mar 11
[PubMed PMID: 18334580]
Level 3 (low-level) evidence
[23]
Bansal V, El Asmar N, Selman WR, Arafah BM. Pitfalls in the diagnosis and management of Cushing's syndrome. Neurosurgical focus. 2015 Feb:38(2):E4. doi: 10.3171/2014.11.FOCUS14704. Epub
[PubMed PMID: 25639322]
[24]
Newell-Price J, Morris DG, Drake WM, Korbonits M, Monson JP, Besser GM, Grossman AB. Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome. The Journal of clinical endocrinology and metabolism. 2002 Apr:87(4):1640-5
[PubMed PMID: 11932295]
[25]
Wagner-Bartak NA, Baiomy A, Habra MA, Mukhi SV, Morani AC, Korivi BR, Waguespack SG, Elsayes KM. Cushing Syndrome: Diagnostic Workup and Imaging Features, With Clinical and Pathologic Correlation. AJR. American journal of roentgenology. 2017 Jul:209(1):19-32. doi: 10.2214/AJR.16.17290. Epub
[PubMed PMID: 28639924]
[26]
Teixeira SR, Elias PC, Andrade MT, Melo AF, Elias Junior J. The role of imaging in congenital adrenal hyperplasia. Arquivos brasileiros de endocrinologia e metabologia. 2014 Oct:58(7):701-8
[PubMed PMID: 25372578]
[27]
Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, Montori VM, Oberfield SE, Ritzen M, White PC, Endocrine Society. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. The Journal of clinical endocrinology and metabolism. 2010 Sep:95(9):4133-60. doi: 10.1210/jc.2009-2631. Epub
[PubMed PMID: 20823466]
[28]
Kaye CI, Committee on Genetics, Accurso F, La Franchi S, Lane PA, Hope N, Sonya P, G Bradley S, Michele A LP. Newborn screening fact sheets. Pediatrics. 2006 Sep:118(3):e934-63
[PubMed PMID: 16950973]
[29]
Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ, Klibanski A, Lacroix A, Lindsay JR, Newell-Price J, Nieman LK, Petersenn S, Sonino N, Stalla GK, Swearingen B, Vance ML, Wass JA, Boscaro M. Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. The Journal of clinical endocrinology and metabolism. 2008 Jul:93(7):2454-62. doi: 10.1210/jc.2007-2734. Epub 2008 Apr 15
[PubMed PMID: 18413427]
[30]
Hammer GD, Tyrrell JB, Lamborn KR, Applebury CB, Hannegan ET, Bell S, Rahl R, Lu A, Wilson CB. Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results. The Journal of clinical endocrinology and metabolism. 2004 Dec:89(12):6348-57
[PubMed PMID: 15579802]
[31]
Starke RM, Reames DL, Chen CJ, Laws ER, Jane JA Jr. Endoscopic transsphenoidal surgery for cushing disease: techniques, outcomes, and predictors of remission. Neurosurgery. 2013 Feb:72(2):240-7; discussion 247. doi: 10.1227/NEU.0b013e31827b966a. Epub
[PubMed PMID: 23149974]
[32]
Wannachalee T, Turcu AF, Auchus RJ. Mifepristone in the treatment of the ectopic adrenocorticotropic hormone syndrome. Clinical endocrinology. 2018 Nov:89(5):570-576. doi: 10.1111/cen.13818. Epub 2018 Aug 14
[PubMed PMID: 30019523]
[33]
Doppman JL, Chrousos GP, Papanicolaou DA, Stratakis CA, Alexander HR, Nieman LK. Adrenocorticotropin-independent macronodular adrenal hyperplasia: an uncommon cause of primary adrenal hypercortisolism. Radiology. 2000 Sep:216(3):797-802
[PubMed PMID: 10966714]
[34]
McNicol AM. Lesions of the adrenal cortex. Archives of pathology & laboratory medicine. 2008 Aug:132(8):1263-71
[PubMed PMID: 18684025]
[35]
Kulis T, Knezevic N, Pekez M, Kastelan D, Grkovic M, Kastelan Z. Laparoscopic adrenalectomy: lessons learned from 306 cases. Journal of laparoendoscopic & advanced surgical techniques. Part A. 2012 Jan-Feb:22(1):22-6. doi: 10.1089/lap.2011.0376. Epub 2011 Dec 13
[PubMed PMID: 22166088]
Level 3 (low-level) evidence
[36]
Baguet JP, Hammer L, Mazzuco TL, Chabre O, Mallion JM, Sturm N, Chaffanjon P. Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients. European journal of endocrinology. 2004 May:150(5):681-6
[PubMed PMID: 15132724]
Level 2 (mid-level) evidence
[37]
Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, Harris EL, Lee JK, Oertel YC, Posner MC, Schlechte JA, Wieand HS. Management of the clinically inapparent adrenal mass ("incidentaloma"). Annals of internal medicine. 2003 Mar 4:138(5):424-9
[PubMed PMID: 12614096]
[38]
Terzolo M, Stigliano A, Chiodini I, Loli P, Furlani L, Arnaldi G, Reimondo G, Pia A, Toscano V, Zini M, Borretta G, Papini E, Garofalo P, Allolio B, Dupas B, Mantero F, Tabarin A, Italian Association of Clinical Endocrinologists. AME position statement on adrenal incidentaloma. European journal of endocrinology. 2011 Jun:164(6):851-70. doi: 10.1530/EJE-10-1147. Epub 2011 Apr 6
[PubMed PMID: 21471169]
[39]
Young WF Jr. Clinical practice. The incidentally discovered adrenal mass. The New England journal of medicine. 2007 Feb 8:356(6):601-10
[PubMed PMID: 17287480]
[40]
Tabarin A, Bardet S, Bertherat J, Dupas B, Chabre O, Hamoir E, Laurent F, Tenenbaum F, Cazalda M, Lefebvre H, Valli N, Rohmer V, French Society of Endocrinology Consensus. Exploration and management of adrenal incidentalomas. French Society of Endocrinology Consensus. Annales d'endocrinologie. 2008 Dec:69(6):487-500. doi: 10.1016/j.ando.2008.09.003. Epub 2008 Nov 20
[PubMed PMID: 19022420]
[41]
. NIH state-of-the-science statement on management of the clinically inapparent adrenal mass ("incidentaloma"). NIH consensus and state-of-the-science statements. 2002 Feb 4-6:19(2):1-25
[PubMed PMID: 14768652]
[42]
El Ghorayeb N, Bourdeau I, Lacroix A. Multiple aberrant hormone receptors in Cushing's syndrome. European journal of endocrinology. 2015 Oct:173(4):M45-60. doi: 10.1530/EJE-15-0200. Epub 2015 May 13
[PubMed PMID: 25971648]
[43]
Albiger NM, Ceccato F, Zilio M, Barbot M, Occhi G, Rizzati S, Fassina A, Mantero F, Boscaro M, Iacobone M, Scaroni C. An analysis of different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: a single-centre experience. Clinical endocrinology. 2015 Jun:82(6):808-15. doi: 10.1111/cen.12763. Epub 2015 Mar 27
[PubMed PMID: 25727927]
[44]
Xu Y, Rui W, Qi Y, Zhang C, Zhao J, Wang X, Wu Y, Zhu Q, Shen Z, Ning G, Zhu Y. The role of unilateral adrenalectomy in corticotropin-independent bilateral adrenocortical hyperplasias. World journal of surgery. 2013 Jul:37(7):1626-32. doi: 10.1007/s00268-013-2059-9. Epub
[PubMed PMID: 23592061]
[45]
Perogamvros I, Vassiliadi DA, Karapanou O, Botoula E, Tzanela M, Tsagarakis S. Biochemical and clinical benefits of unilateral adrenalectomy in patients with subclinical hypercortisolism and bilateral adrenal incidentalomas. European journal of endocrinology. 2015 Dec:173(6):719-25. doi: 10.1530/EJE-15-0566. Epub 2015 Sep 1
[PubMed PMID: 26330465]
[46]
Castinetti F, Taieb D, Henry JF, Walz M, Guerin C, Brue T, Conte-Devolx B, Neumann HP, Sebag F. MANAGEMENT OF ENDOCRINE DISEASE: Outcome of adrenal sparing surgery in heritable pheochromocytoma. European journal of endocrinology. 2016 Jan:174(1):R9-18. doi: 10.1530/EJE-15-0549. Epub 2015 Aug 21
[PubMed PMID: 26297495]
[47]
Ou YC, Yang CR, Chang CL, Chang CH, Wu HC, Ho HC, Lin HS, Chang YY. Prognostic factors of primary aldosteronism. Zhonghua yi xue za zhi = Chinese medical journal; Free China ed. 1996 Feb:57(2):118-23
[PubMed PMID: 8634926]
[48]
Gumbs AA, Gagner M. Laparoscopic adrenalectomy. Best practice & research. Clinical endocrinology & metabolism. 2006 Sep:20(3):483-99
[PubMed PMID: 16980207]
[49]
Karduss Urueta A, Morales Polanco MR, Pizzuto Chávez J, Meillón García LA. [Results of the treatment of chronic idiopathic thrombocytopenic purpura with ascorbic acid]. Gaceta medica de Mexico. 1993 Jan-Feb:129(1):23-5
[PubMed PMID: 8063073]
[50]
Araujo-Castro M,Marazuela M, Cushing´s syndrome due to bilateral adrenal cortical disease: Bilateral macronodular adrenal cortical disease and bilateral micronodular adrenal cortical disease. Frontiers in endocrinology. 2022;
[PubMed PMID: 35992106]